News & Events

Workgroup assignments

Updated September 3, 2008

PDF Version of the Workgroup assignments

CRMO/SAPHO Workgroups:

Runs discussion in small workgroup
Presents and discusses results in big group after the small group session
On Wednesday and Thursday afternoon we will have 2 big group discussions, one on the clinical and one the biomarker outcomes. In order to avoid redundancy with repeating outcomes in the one single group which is formed to discuss a clinical trial design, we would like for the individual highlighted in green to present the respective big group discussions to the other big group. After the mutual update on the respective discussion in the “other” big group, the session on clinical trial design will be started.
Representative of “clinical big group” who presents to “biomarker big group” and representative of “biomarker big group” who presents to “clinical big group”

WEDNESDAY AFTERNOON 9/3/08, 2:30pm to 5pm:
Small group discussions are from 2:30pm to 3:30pm
Big group discussions are from 3:30pm to 4:30pm
7 Small Workgroups:

1. CLINILCAL TRIAL ENTRY CRITERIA (AUDITORIUM)
C Wallace
Laxer
Ozen
Barron
Miettunen

2. CLINICAL RHEUM and REHAB ENDPOINTS (CHAPEL)
Giannini
Inman
Lehman
Paul
Ward
Dancey
Goldbach-Mansky
(rehab representatives)

3. BONE IMAGING (CLASSROOM 162A)
Khanna
Job-Deslandre
Hill
Yao
Chen, Clara?
Reynolds

4. SKIN SCORING (CLASSROOM 162 B)
Cowen
Fuhlbrigge
Turner

5. GASTROINTESTINAL EVALUTION (BALCONY)
Strober
Ishigatsubo
Douek
Kelsall

6. BONE MARKERS (FOYER)
Novack
Ferguson
Collins
Uzel

7. INFLAMMTORY/GENETIC MARKERS (RATHSKELLER)
Kastner
Wallace G
El-Shanti
Holland
Colbert
Aksentijevich
Elaine
Gordon
Siegel

2 BIG GROUPS:

CLINICAL: (AUDITORIUM)
Giannini
Ron Laxer
Bone imaging
Skin scoring
Entry criteria
Rheum and rehab outcomes

BIOMARKER: (RATHSKELLER)
El-Shanti
Dan Kastner
Inflammation
Bone
GI

BEHCET’S DISEASE Workgroups:
THURSDAY AFTERNOON 9/4/08, 2:30pm to 5pm:
Small group discussions are from 2:30pm to 3:30pm
Big group discussions are from 3:30pm to 4:30pm
6 Small Workgroups:

1. CLINILCAL TRIAL ENTRY CRITERIA (AUDITORIUM)
Wallace C
Yazici H
Yazici, Y
Seyahi
Rider
Lehman
Uzel

2. CLINICAL RHEUM AND REHAB ENDPOINTS (CHAPEL)
Giannini
Ozen
Paul
Ward
Goldbach-Mansky
Dancey
(rehab representatives)

3. SKIN AND MUCOSAL SCORING GROUP (CLASSROOM 162A)
Turner
Fuhlbrigge
Cowen
Stratton
Nikolov
Zouboulis?

4. VASCULAR AND GASTOENTERAL MANIFESTATIONS AND BIOMARKERS (CLASSROOM 162B)
(GI was likely discussed in the Wednesday session on GI manifestations in CRMO/SAPHO may therefore concentrate on vascular manifestations)
Laxer
Ishigatsubo
Barron
Chen, vascular imaging?

5. INFLAMMTORY MARKERS (RATHSKELLER)
Colbert
Kastner
Wallace G
Holland
Siegel
Gadina

6. GENETICS GROUP (FOYER)
Aksentijevich
Gul
Remmers
Kone-Paut
Ferguson
El-Shanti

2 BIG GROUPS:

CLINICAL: (AUDITORIUM)
Giannini
Yazici Y
Skin and mucosal scoring
Entry criteria
Rheum and rehab outcomes

BIOMARKER: (RATHSKELLER)
Wallace C
Ahmet Gul
Vascular
GI
Inflammatory

FRIDAY MORNING WORKSHOPS 9/05/08, 9:45am to 12 noon:
Small group discussions are from 9:45am to 11:00am
Big group discussions are from 11:00am to 12:000noon
3 Small Workgroups:

1. SKIN AND MUCOSAL IMMUNOLOGY (Friday) (CLASSROOM 162 A)
Zouboulis
Lowes
Gordon
Wallace G
Lee R
Cowen
Turner

2. OPHTHALMOLOGICAL EVALUATION (Friday) (CLASSROOM 162 B)
Bodaghi
Sen
Tugal-Tutkun
Wallace G
Nussenblatt??
J Smith

3. ASSESSING “UNMET NEEDS” IN BEHCET”S DISEASE-INSIGHTS FROM RCT
Yazici H
Gul
Yazici Y
Kone-Paut
Job-Deslandre
Seyahi

4. LOGISTICS OF SHARING CLINICAL AND BIOMARKER DATA AND STUDY PROCEDURES (AUDITORIUM)
Giannini
Fuhlbrigge
Ferguson
Wallace C
Ozen
Rider
Colbert
Dancey
Goldbach-Mansky
Serrate-Sztein?

1 BIG GROUP: (AUDITORIUM)
Giannini
Wallace C
All groups
SKIN IMMUNOLOGY
OPHTHALMOLOGICAL EVALUATION
SHARING CLINICAL AND BIOMARKER DATA, STUDY PROCEDURES AND CONDUCTING CLINICAL TRIALS